Aardvark Therapeutics, Inc. (AARD)
4.54
+0.03
(+0.67%)
USD |
NASDAQ |
May 22, 16:00
4.51
-0.03
(-0.66%)
After-Hours: 20:00
Aardvark Therapeutics EPS Diluted (Quarterly) : -0.9896 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Alumis, Inc. | -0.7441 |
| SIGA Technologies, Inc. | -0.0482 |
| Zoetis, Inc. | 1.423 |
| ANI Pharmaceuticals, Inc. | 1.276 |
| Corcept Therapeutics, Inc. | -0.2988 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -21.59M |
| Total Expenses (Quarterly) | 21.59M |
| Enterprise Value | 8.182M |
| Earnings Yield | -70.68% |
| Normalized Earnings Yield | -70.68 |